MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
MiMedx's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $17.97M, down 4.6% from the year before. Over ten years it grew 16.6% a year on average. The highest annual figure on record is $65.66M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.97M | -4.6% |
| FY2024 | Dec 31, 2024 | $18.83M | -61.6% |
| FY2023 | Dec 31, 2023 | $49.10M | +1.0% |
| FY2022 | Dec 31, 2022 | $48.59M | +1.0% |
| FY2021 | Dec 31, 2021 | $48.13M | +0.9% |
| FY2020 | Dec 31, 2020 | $47.70M | -27.4% |
| FY2019 | Dec 31, 2019 | $65.66M | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $4.01M | +3.6% |
| FY2011 | Dec 31, 2011 | $3.87M | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $17.21M | -6.8% |
| Q1 FY2026 | Mar 31, 2026 | $17.59M | -5.7% |
| Q4 FY2025 | Dec 31, 2025 | $17.97M | -4.6% |
| Q3 FY2025 | Sep 30, 2025 | $18.21M | -4.2% |
| Q2 FY2025 | Jun 30, 2025 | $18.46M | -4.1% |
| Q1 FY2025 | Mar 31, 2025 | $18.66M | -4.1% |
| Q4 FY2024 | Dec 31, 2024 | $18.83M | -61.6% |
| Q3 FY2024 | Sep 30, 2024 | $19.02M | -61.2% |
| Q2 FY2024 | Jun 30, 2024 | $19.25M | -60.6% |
| Q1 FY2024 | Mar 31, 2024 | $19.45M | -60.1% |
| Q4 FY2023 | Dec 31, 2023 | $49.10M | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | $48.97M | +1.0% |
| Q2 FY2023 | Jun 30, 2023 | $48.84M | +1.0% |
| Q1 FY2023 | Mar 31, 2023 | $48.71M | +1.0% |
| Q4 FY2022 | Dec 31, 2022 | $48.59M | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | $48.48M | +1.0% |
| Q2 FY2022 | Jun 30, 2022 | $48.36M | +0.9% |
| Q1 FY2022 | Mar 31, 2022 | $48.24M | +0.9% |
| Q4 FY2021 | Dec 31, 2021 | $48.13M | +0.9% |
| Q3 FY2021 | Sep 30, 2021 | $48.02M | +0.8% |
| Q2 FY2021 | Jun 30, 2021 | $47.91M | -26.6% |
| Q1 FY2021 | Mar 31, 2021 | $47.80M | -26.9% |
| Q4 FY2020 | Dec 31, 2020 | $47.70M | -27.4% |
| Q3 FY2020 | Sep 30, 2020 | $47.63M | -27.8% |
| Q2 FY2020 | Jun 30, 2020 | $65.22M | -2.4% |
| Q1 FY2020 | Mar 31, 2020 | $65.39M | – |
| Q4 FY2019 | Dec 31, 2019 | $65.66M | – |
| Q3 FY2019 | Sep 30, 2019 | $65.92M | – |
| Q2 FY2019 | Jun 30, 2019 | $66.82M | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
See a number that looks wrong?